ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Montana » Pulmonary Disease

Top Pulmonary Disease Prescribers in Montana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANDERS PERSSON MD

Pulmonary Disease

3,026

$445K

198
166 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 57%

$147
Average prescription price

Avg: $195

ROBERT PUERINGER MD

Pulmonary Disease

2,592

$646K

270
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 57%

$249
Average prescription price

Avg: $195

CATHERINE STEPHENS MD

Pulmonary Disease

2,208

$335K

279
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 57%

$152
Average prescription price

Avg: $195

TIMOTHY OBERMILLER M.D.

Pulmonary Disease

2,070

$398K

250
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 57%

$192
Average prescription price

Avg: $195

KEITH POPOVICH M.D.

Pulmonary Disease

1,830

$284K

174
138 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 57%

$155
Average prescription price

Avg: $195

RICHARD BLEVINS MD

Pulmonary Disease

1,497

$202K

169
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 57%

$135
Average prescription price

Avg: $195

WILLIAM BEKEMEYER MD

Pulmonary Disease

1,488

$400K

228
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 57%

$269
Average prescription price

Avg: $195

JOHN MAZUR M.D.

Pulmonary Disease

1,244

$137K

130
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 57%

$110
Average prescription price

Avg: $195

FREDERICK KAHN M.D.

Pulmonary Disease

1,221

$259K

158
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 57%

$212
Average prescription price

Avg: $195

ROBERT ROLLINS MD

Pulmonary Disease

1,188

$208K

171
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 57%

$175
Average prescription price

Avg: $195

SETH CLEMENS M.D.

Pulmonary Disease

1,110

$129K

146
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 57%

$116
Average prescription price

Avg: $195

ROBERT MERCHANT MD

Pulmonary Disease

1,011

$218K

156
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 57%

$216
Average prescription price

Avg: $195

ANTHONY DAL NOGARE MD

Pulmonary Disease

784

$208K

124
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 57%

$265
Average prescription price

Avg: $195

BRENT PISTORESE MD

Pulmonary Disease

775

$131K

105
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 57%

$169
Average prescription price

Avg: $195

RICHARD SELLMAN M.D.

Pulmonary Disease

659

$258K

98
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 57%

$391
Average prescription price

Avg: $195

ROBERT GRASSESCHI MD

Pulmonary Disease

618

$250K

76
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$405
Average prescription price

Avg: $195

JAMES MCMEEKIN M.D.

Pulmonary Disease

404

$89.5K

54
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

81%
prescriptions for brand name drugs

Avg: 57%

$221
Average prescription price

Avg: $195

BRENDAN BELLEW M.D.

Pulmonary Disease

363

$97.2K

111
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 57%

$268
Average prescription price

Avg: $195

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank